In summary, several markers showed substantially elevated expression levels between ovarian cancer compared with benign conditions in publically available expression data and our proof of concept study (including recently suggested marker FGF18) for ovarian cancer prediction [22]. This evidence concerns the gene FGF18 and ovarian carcinoma.